Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Baudax Bio, Inc. | 83,333 | reported | 07 Apr 2021 | tx 7+227,310 |
| INSMED Inc | 69,495 | reported | 13 May 2024 | tx 21+120,450−55,282 |
| Recro Pharma, Inc. | 44,196 | reported | 05 Dec 2019 | tx 13+135,065−13,274 |
| AUXILIUM PHARMACEUTICALS INC | 15,000 | reported | 16 Jun 2011 | tx 9+105,000−30,000 |
| BARRIER THERAPEUTICS INC |
| 0 |
| reported |
| 06 Aug 2008 |
| tx 12+555,000−511,106 |
| AGILE THERAPEUTICS INC | 0 | reported | 26 Aug 2024 | tx 54+4,718,943−371,703 |
| DUSA PHARMACEUTICALS INC | 0 | reported | 20 Dec 2012 | tx 8+35,000−35,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 Aug 2024 | OTHER | AGILE THERAPEUTICS INC | 19,624 | 1.52 USD | |
| 26 Aug 2024 | OTHER | AGILE THERAPEUTICS INC | 28,125 | 1.52 USD | |
| 13 May 2024 | GRANT_AWARD | INSMED Inc | 13,162 | — | |
| 28 Jun 2023 | GRANT_AWARD | AGILE THERAPEUTICS INC | 37,500 | 0.00 USD | |
| 28 Jun 2023 | GRANT_AWARD | AGILE THERAPEUTICS INC | 8,963 | 0.00 USD | |
| 28 Jun 2023 | GRANT_AWARD | AGILE THERAPEUTICS INC | 12,500 | 0.00 USD | deriv |
| 11 May 2023 | GRANT_AWARD | INSMED Inc | 13,192 | — | |
| 09 Nov 2022 | GRANT_AWARD | AGILE THERAPEUTICS INC | 30,000 | 0.00 USD | deriv |
| 26 Aug 2022 | PURCHASE | AGILE THERAPEUTICS INC | 50,000 | 0.45 USD | |
| 11 May 2022 | GRANT_AWARD | INSMED Inc | 14,645 | — | |
| 19 Jan 2022 | GRANT_AWARD | AGILE THERAPEUTICS INC | 675,000 | 0.00 USD | deriv |
| 13 Oct 2021 | PURCHASE | AGILE THERAPEUTICS INC | 58,824 | — | |
| 13 Oct 2021 | PURCHASE | AGILE THERAPEUTICS INC | 29,412 | — | deriv |
| 29 Jul 2021 | PURCHASE | AGILE THERAPEUTICS INC | 26,200 | 1.26 USD | |
| 18 May 2021 | PURCHASE | AGILE THERAPEUTICS INC | 20,000 | 1.61 USD | |
| 12 May 2021 | GRANT_AWARD | INSMED Inc | 7,558 | — | |
| 07 Apr 2021 | GRANT_AWARD | Baudax Bio, Inc. | 56,452 | 0.00 USD | |
| 07 Apr 2021 | GRANT_AWARD | Baudax Bio, Inc. | 83,333 | 0.00 USD | deriv |
| 23 Mar 2021 | PURCHASE | AGILE THERAPEUTICS INC | 12,500 | 2.00 USD | |
| 27 Jan 2021 | GRANT_AWARD | AGILE THERAPEUTICS INC | 692,641 | 0.00 USD | deriv |
| 07 Dec 2020 | SALE | INSMED Inc | 20,000 | 39.57 USD | |
| 23 Nov 2020 | PURCHASE | Baudax Bio, Inc. | 5,000 | 1.06 USD | |
| 20 Aug 2020 | EXERCISE | AGILE THERAPEUTICS INC | 94,599 | 1.76 USD | |
| 20 Aug 2020 | EXERCISE | AGILE THERAPEUTICS INC | 94,599 | 0.00 USD | deriv |
| 22 Jun 2020 | EXERCISE | AGILE THERAPEUTICS INC | 50,000 | 1.76 USD |
4 purchases reported after at least 12 months of silence — most recent on 25 Mar 2019.